A prosthetic disc nucleus, also known as an artificial disc nucleus or artificial intervertebral disc nucleus, is a medical tool used to replace or supplement the nucleus pulposus of a damaged or deteriorated intervertebral disc in the spine. These discs are located between the vertebrae in the spine and act as shock absorbers, allowing for flexibility and movement. Prosthetic disc nuclei are utilized to treat various spinal conditions, such as degenerative disc disease, herniated discs, and other disc-related issues, which can cause discomfort, restricted mobility, and other symptoms. The use of prosthetic disc nuclei offers several benefits, including pain relief, enhanced spinal mobility, and preservation of spine function. In contrast to traditional spinal fusion surgery, which immobilizes the affected area of the spine, these devices aim to allow for more natural movement.
The global prosthetic disc nucleus market was valued at US$ 103.7 Million in 2022 and is anticipated to reach US$ 204.5 Million by the end of 2030 with a CAGR of 8.9% from 2023 to 2030.
To implant a prosthetic disc nucleus, surgery is typically required. The specific procedure may vary depending on the type of device and the patient’s condition. Surgeons make an incision, remove the damaged disc, and insert the prosthetic device.
Prosthetic Disc Nucleus to Recover Amid COVID-19 Pandemic
The COVID-19 pandemic has had a significant impact on the healthcare industry and medical device markets, specifically in the prosthetic disc nucleus market. Due to the pandemic, many elective surgeries, such as those involving prosthetic disc nucleus implantation, were postponed, or cancelled to free up hospital resources, reduce the risk of virus transmission, and protect healthcare workers. As a result, there is now a backlog of patients awaiting procedures.
The pandemic has also disrupted global supply chains, which have affected the production and distribution of medical devices, including prosthetic disc nuclei. Manufacturers have struggled to source materials and components, which could potentially delay the availability of these devices. Additionally, the economic uncertainties resulting from the pandemic have led to financial constraints for healthcare institutions and individuals. Some patients may have decided to delay or forgo elective surgeries, such as disc nucleus replacement, due to concerns about healthcare costs and job security.
Increasing Prevalence of Chronic Diseases to Boost Prosthetic Disc Nucleus Market
The rising prevalence of spinal disorders such as degenerative disc disease and spinal stenosis has increased the use of spine implants. Every year, an estimated 266 million people suffer from lumbar degenerative spine disorder and low back pain. According to the Hebrew SeniorLife Institute for Aging Research, one-third of people aged 40 to 59 have moderate to severe degenerative disc disease, and half of the population has moderate to severe osteoarthritis. In people aged 60 to 69 years and 70 to 89 years, the prevalence of disc height narrowing and joint osteoarthritis increased by 2 to 4 times, respectively.
Spinal disorders are a significant public health and social concern because they are major causes of disability worldwide. Regardless of the actual diagnosis or cause of the condition, respondents frequently report a spine disorder as lower back pain. Thus, the high prevalence and rising incidence rate of spine disorders globally is expected to drive the prosthetic disc nucleus market during the forecast period.
North America to Spearhead Prosthetic Disc Nucleus Market
North America dominated the global prosthetic disc nucleus market in 2019, followed by Europe, and the trend is anticipated to continue during the forecast period. The region’s dominance can be ascribed to the high prevalence and rise in incidence rates of degenerative disc disorder, the well-established healthcare industry, and the increase in geriatric population in the region.
From 2022 to 2030, the Asia Pacific prosthetic disc nucleus market is expected to grow at a significant CAGR. The region’s market expansion can be attributed to the adoption of new technologies, high awareness, significant healthcare spending, early availability of advanced technologies, and regional penetration of research activities.
Several companies, such as Stryker Corporation, Zimmer Biomet Holdings Inc., DePuy Synthes (Johnson & Johnson), NuVasive Inc., Orthofix International N.V., Replication Medical Inc., and Spine Wave Inc. have implemented various growth strategies.
These strategies include forming partnerships and collaborations to accelerate the development of prosthetic disc nucleus treatments, investing in research and development to improve existing products and create new ones, expanding their geographical presence, acquiring or merging with other companies to expand capabilities and product offerings, and investing in marketing and promotional activities to increase awareness and demand for their products. These growth strategies enable companies to enhance their market presence, generate revenue, and offer innovative solutions to the global prosthetic disc nucleus market.